{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,9,3]],"date-time":"2026-09-03T22:42:03Z","timestamp":1788475323123,"version":"build-2803163510"},"reference-count":22,"publisher":"Elsevier BV","issue":"3","license":[{"start":{"date-parts":[[2005,5,1]],"date-time":"2005-05-01T00:00:00Z","timestamp":1114905600000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"}],"content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":["Journal of Diabetes and its Complications"],"published-print":{"date-parts":[[2005,5]]},"DOI":"10.1016\/j.jdiacomp.2004.09.004","type":"journal-article","created":{"date-parts":[[2005,4,30]],"date-time":"2005-04-30T11:22:13Z","timestamp":1114860133000},"page":"133-137","source":"Crossref","is-referenced-by-count":5,"title":["Prevalence of antiphospholipid antibodies is not different in Chilean diabetic patients and normal individuals"],"prefix":"10.1016","volume":"19","author":[{"given":"Iv\u00e1n G.","family":"Palomo","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Ver\u00f3nica E.","family":"Mujica","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Marcelo L.","family":"Alarc\u00f3n","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Jaime G.","family":"Pereira","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Marcela R.","family":"V\u00e1squez","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"78","reference":[{"key":"10.1016\/j.jdiacomp.2004.09.004_bib1","doi-asserted-by":"crossref","first-page":"331","DOI":"10.1016\/S0889-857X(05)70141-1","article-title":"Antiphospholipid (Hughes) syndrome in systemic lupus erythematosus","volume":"26","author":"Amigo","year":"2000","journal-title":"Rheumatic Disease Clinics of North America"},{"key":"10.1016\/j.jdiacomp.2004.09.004_bib2","doi-asserted-by":"crossref","first-page":"1120","DOI":"10.1055\/s-0038-1649891","article-title":"Development of an ELISA for autoantibodies to prothrombin showing their prevalence in patients with lupus anticoagulants","volume":"74","author":"Arvieux","year":"1995","journal-title":"Thrombosis and Haemostasis"},{"key":"10.1016\/j.jdiacomp.2004.09.004_bib3","doi-asserted-by":"crossref","first-page":"748","DOI":"10.1177\/000313480006600812","article-title":"The antiphospholipid syndrome in a teenage with miscarriage, thrombosis, and diabetes mellitus","volume":"66","author":"Best","year":"2000","journal-title":"American Surgeon"},{"key":"10.1016\/j.jdiacomp.2004.09.004_bib4","doi-asserted-by":"crossref","first-page":"241","DOI":"10.1016\/S0021-9150(01)00440-3","article-title":"Autoantibodies and endothelial dysfunction in well-controlled, uncomplicated insulin-dependent diabetes mellitus patients","volume":"158","author":"Ciarla","year":"2001","journal-title":"Atherosclerosis"},{"key":"10.1016\/j.jdiacomp.2004.09.004_bib5","doi-asserted-by":"crossref","first-page":"143","DOI":"10.1111\/j.1365-2141.1978.tb03648.x","article-title":"A sensitive test demonstrating lupus anticoagulant and its behavioural patterns","volume":"40","author":"Exner","year":"1978","journal-title":"British Journal of Haematology"},{"key":"10.1016\/j.jdiacomp.2004.09.004_bib6","doi-asserted-by":"crossref","first-page":"469","DOI":"10.1191\/096120398678920488","article-title":"Vascular complications of diabetes mellitus: what role for phospholipid-binding antibodies?","volume":"7","author":"Galtier-Dereure","year":"1998","journal-title":"Lupus"},{"key":"10.1016\/j.jdiacomp.2004.09.004_bib7","doi-asserted-by":"crossref","first-page":"30","DOI":"10.1046\/j.1365-2249.1999.01014.x","article-title":"Qualitative and quantitative studies of autoantibodies to phospholipid in diabetes mellitus","volume":"118","author":"Gargiulo","year":"1999","journal-title":"Clinical and Experimental Immunology"},{"issue":"2","key":"10.1016\/j.jdiacomp.2004.09.004_bib8","doi-asserted-by":"crossref","first-page":"235","DOI":"10.1016\/j.mehy.2004.02.019","article-title":"Are phospholipid-binding antibodies implicated in the pathogenesis of diabetic microangiopathy?","volume":"63","author":"Giusti","year":"2004","journal-title":"Medical Hypotheses"},{"key":"10.1016\/j.jdiacomp.2004.09.004_bib9","doi-asserted-by":"crossref","first-page":"531","DOI":"10.1136\/bjo.84.5.531","article-title":"Lupus anticoagulant positivity in insulin dependent diabetic patients: an additional risk factor in the pathogenesis of diabetic retinopathy?","volume":"84","author":"Giusti","year":"2000","journal-title":"British Journal of Ophthalmology"},{"key":"10.1016\/j.jdiacomp.2004.09.004_bib10","doi-asserted-by":"crossref","first-page":"1","DOI":"10.1111\/j.1365-2141.1990.tb02530.x","article-title":"Antiphospholipid antibodies","volume":"74","author":"Harris","year":"1990","journal-title":"British Journal of Haematology"},{"key":"10.1016\/j.jdiacomp.2004.09.004_bib11","first-page":"254","article-title":"Lupus anticoagulants and thrombosis: a study of 25 cases and review of the literature","volume":"15","author":"Lechner","year":"1985","journal-title":"Haemostasis"},{"key":"10.1016\/j.jdiacomp.2004.09.004_bib12","first-page":"738","article-title":"Measurement of anticardiolipin antibodies by enzyme-linked immunosorbent assay (ELISA): standardizations and quantitation of results","volume":"62","author":"Loizou","year":"1985","journal-title":"Clinical and Experimental Immunology"},{"key":"10.1016\/j.jdiacomp.2004.09.004_bib13","doi-asserted-by":"crossref","first-page":"457","DOI":"10.1084\/jem.179.2.457","article-title":"Anticardiolipin antibodies recognize \u03b22glycoprotein I structure altered by interacting with an oxygen modified solid phase surface","volume":"179","author":"Matsuura","year":"1994","journal-title":"Journal of Experimental Medicine"},{"key":"10.1016\/j.jdiacomp.2004.09.004_bib14","doi-asserted-by":"crossref","first-page":"1148","DOI":"10.1053\/meta.2002.34705","article-title":"Anticardiolipin antibodies in children with insulin-dependent diabetes mellitus","volume":"51","author":"Mohamed","year":"2002","journal-title":"Metabolism"},{"key":"10.1016\/j.jdiacomp.2004.09.004_bib15","doi-asserted-by":"crossref","first-page":"326","DOI":"10.1016\/S0049-0172(99)80017-1","article-title":"Associations of antiphospholipid antibodies with retinal vascular disease in systemic lupus erythematosus","volume":"28","author":"Montehermoso","year":"1999","journal-title":"Seminars in Arthritis and Rheumatism"},{"key":"10.1016\/j.jdiacomp.2004.09.004_bib16","doi-asserted-by":"crossref","first-page":"1039","DOI":"10.2337\/diab.28.12.1039","article-title":"Classification of diabetes mellitus and other categories of glucose intolerance","volume":"28","year":"1979","journal-title":"Diabetes"},{"key":"10.1016\/j.jdiacomp.2004.09.004_bib17","doi-asserted-by":"crossref","first-page":"295","DOI":"10.1016\/S1056-8727(00)00078-7","article-title":"A 6-year nationwide cohort study of glycaemic control in young people with type 1 diabetes. Risk markers for the development of retinopathy, nephropathy and neuropathy. Danish Study Group of Diabetes in Childhood","volume":"14","author":"Olsen","year":"2000","journal-title":"Journal of Diabetes and its Complications"},{"key":"10.1016\/j.jdiacomp.2004.09.004_bib18","doi-asserted-by":"crossref","first-page":"336","DOI":"10.1067\/mlc.2002.128467","article-title":"Antiphospholipid antibodies in Chilean patients with systemic lupus erythematosus","volume":"140","author":"Palomo","year":"2002","journal-title":"Journal of Laboratory and Clinical Medicine"},{"key":"10.1016\/j.jdiacomp.2004.09.004_bib19","doi-asserted-by":"crossref","first-page":"499","DOI":"10.1182\/blood.V48.4.499.499","article-title":"A clinical study of the lupus anticoagulant","volume":"48","author":"Schleider","year":"1976","journal-title":"Blood"},{"key":"10.1016\/j.jdiacomp.2004.09.004_bib20","doi-asserted-by":"crossref","first-page":"977","DOI":"10.1056\/NEJM199309303291401","article-title":"The effect of intensive treatment of diabetes on the development and progression of long-term complications in insulin-dependent diabetes mellitus","volume":"329","year":"1993","journal-title":"New England Journal of Medicine"},{"key":"10.1016\/j.jdiacomp.2004.09.004_bib21","series-title":"Immunological obstetrics","first-page":"377","article-title":"Obstetrical complications associated with antiphospholipid antibodies","author":"Triplett","year":"1992"},{"key":"10.1016\/j.jdiacomp.2004.09.004_bib22","doi-asserted-by":"crossref","first-page":"837","DOI":"10.1016\/S0140-6736(98)07019-6","article-title":"Intensive blood-glucose control with sulphonylureas or insulin compared with conventional treatment and risk of complications in patients with type 2 diabetes","volume":"352","year":"1998","journal-title":"Lancet"}],"container-title":["Journal of Diabetes and its Complications"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S105687270400100X?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S105687270400100X?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2023,5,3]],"date-time":"2023-05-03T03:47:13Z","timestamp":1683085633000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S105687270400100X"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2005,5]]},"references-count":22,"journal-issue":{"issue":"3","published-print":{"date-parts":[[2005,5]]}},"alternative-id":["S105687270400100X"],"URL":"https:\/\/doi.org\/10.1016\/j.jdiacomp.2004.09.004","relation":{},"ISSN":["1056-8727"],"issn-type":[{"value":"1056-8727","type":"print"}],"subject":[],"published":{"date-parts":[[2005,5]]}}}